Charles River Laboratories International (CRL) Revenue — Quarter Ended Dec 28, 2024
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same period a year earlier. The quarterly performance continues a pattern of year-over-year declines observed throughout the fiscal year.
Key takeaway
Quarter ended Dec 28, 2024 · FY2024 Q4
Revenue for the quarter decreased compared to both the immediately preceding quarter and the same period a year earlier. The quarterly performance continues a pattern of year-over-year declines observed throughout the fiscal year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1B
Revenue reported for this quarter.
Quarter-over-quarter
-0.7%
Change from the immediately preceding quarter.
Year-over-year
-1.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 30, 2024 | $1B | -1.7% |
| Jun 29, 2024 | $1B | -3.2% |
| Sep 28, 2024 | $1B | -1.6% |
| Dec 28, 2024 | $1B | -1.1% |
Revenue performance
The reported revenue declined from the prior quarter, reflecting a sequential contraction. Compared with the same quarter one year ago, revenue also fell, marking a persistent year-over-year decrease.
Quarterly comparison
The quarter-over-quarter change was negative, and the year-over-year comparison also showed a decline. The trailing twelve-month revenue stood at the level of the full-year figure.
What to watch
Monitor whether the downward revenue trend continues in the upcoming reporting periods.